Get startedLog in
    Picture of Denali Therapeutics logo

    DNLI — Denali Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    All News

    Denali-Sanofi's ALS drug fails to meet main goal of mid-stage trial

    Picture of Denali Therapeutics logoDenali Therapeutics
    16/02/2024 13:22
    Feb 16 (Reuters) - Denali Therapeutics  DNLI.O  said on
Friday it was informed by partner Sanofi  SASY.PA  that their
drug for a type of neurological disease did not meet the main
goal in a mid-stage trial.

 (Reporting by Christy Santhosh; Editing by Shilpi Majumdar)
 ((Christy.Santhosh@thomsonreuters.com;))

    Recent news on Denali Therapeutics

    See all news